Abstract
Background: The incidence of acute coronary syndrome is reported to be higher for males than females, yet clinical outcomes following acute myocardial infarction are worse among females. Information about acute coronary syndrome outcomes is obtained from randomised and cohort data. However, randomised controlled trials which are designed to evaluate the efficacy of clinical interventions often have limited external validity, and observational studies which draw inferences from the effect of an exposure whilst being more generalizable are limited by confounding. Methods: We undertook a structured literature review of research manuscripts published between 2000 and 2015 to examine whether reported sex-dependent outcomes following acute coronary syndrome differed between randomised control trials and observational registries. Results: Of 56 manuscripts, we found consistency between the two types of study designs – each type of study describing worse clinical outcomes for females with acute coronary syndrome. We also found a reduction in the use of guideline recommended therapy in females. Conclusion: Further research is needed to understand at a mechanistic and health services level why such a discrepancy in clinical outcomes exists.
Keywords: Acute coronary syndrome, sex outcomes, trials, registries.
Current Pharmaceutical Design
Title:Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?
Volume: 22 Issue: 25
Author(s): Chris P. Gale and Owen Bebb
Affiliation:
Keywords: Acute coronary syndrome, sex outcomes, trials, registries.
Abstract: Background: The incidence of acute coronary syndrome is reported to be higher for males than females, yet clinical outcomes following acute myocardial infarction are worse among females. Information about acute coronary syndrome outcomes is obtained from randomised and cohort data. However, randomised controlled trials which are designed to evaluate the efficacy of clinical interventions often have limited external validity, and observational studies which draw inferences from the effect of an exposure whilst being more generalizable are limited by confounding. Methods: We undertook a structured literature review of research manuscripts published between 2000 and 2015 to examine whether reported sex-dependent outcomes following acute coronary syndrome differed between randomised control trials and observational registries. Results: Of 56 manuscripts, we found consistency between the two types of study designs – each type of study describing worse clinical outcomes for females with acute coronary syndrome. We also found a reduction in the use of guideline recommended therapy in females. Conclusion: Further research is needed to understand at a mechanistic and health services level why such a discrepancy in clinical outcomes exists.
Export Options
About this article
Cite this article as:
P. Gale Chris and Bebb Owen, Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?, Current Pharmaceutical Design 2016; 22 (25) . https://dx.doi.org/10.2174/1381612822666160426150626
DOI https://dx.doi.org/10.2174/1381612822666160426150626 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Asymmetric Dimethylarginine: A Possible Link between Vascular Disease and Dementia
Current Alzheimer Research Left Atrial Appendage Closure -The WATCHMAN Device
Current Cardiology Reviews Antihyperglycemic and Antidyslipidemic Activities of the <i>Aqueous Salvia hispanica</i> Extract in Diabetic Rat
Cardiovascular & Hematological Agents in Medicinal Chemistry Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design The Fabry Cardiomyopathy - Diagnostic Approach and Current Treatment
Current Pharmaceutical Design Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Evaluation of Cucurbita Argyrosperma as Anti-Angiogenic Chemopreventive, Anti-Diabetic, Anti-Carcinogenic, and Anti-microbial Therapy
Current Traditional Medicine Anti-Inflammatory Responses of Resveratrol
Inflammation & Allergy - Drug Targets (Discontinued) Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review
Current Pharmaceutical Design Hypertension in Egypt: A Systematic Review
Current Hypertension Reviews Protective Effects of Astragalus Membranaceus and Ligustrazine on Rat Brain Microvascular Endothelial Cell Injury after Oxygen-Glucose Deprivation/ Reoxygenation by Suppressing the PKCδ/MARCKS Pathway
Combinatorial Chemistry & High Throughput Screening Wound-Associated Skin Fibrosis: Mechanisms and Treatments Based on Modulating the Inflammatory Response
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effect of Borage (Echium amoenum) on the Mouse Heart and Hematology Parameters
Cardiovascular & Hematological Disorders-Drug Targets Dronedarone – A New Alternative for Management of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Immunosuppressive and Antiviral Treatment of Inflammatory Cardiomyopathy
Recent Patents on Cardiovascular Drug Discovery Measurements of Thermodynamic Acid Dissociation Constants for Three HMG-CoA Reductase Inhibitors by using RPLC and Study of Validation in Pharmaceutical Tablets
Current Pharmaceutical Analysis Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations
Current Pharmaceutical Design Editorial (Hot Topic: Novel Biomarkers in the Prognosis, Progression and Treatment of Cardiovascular Disease: The Role of microRNAs )
Current Topics in Medicinal Chemistry Olive Oil-related Anti-inflammatory Effects on Atherosclerosis: Potential Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets